Aier Healthcare Investment Group

Aier Healthcare Investment Group is the private holding company through which founder Chen Bang and vice chairman Li Li own their controlling stake in the publicly listed Aier Eye Hospital Group. It is not an operating subsidiary but a separate investment vehicle that manages the wealth generated by the hospital chain. The investment group holds Chen's roughly 50% economic interest and Li's balance of the holding, according to public shareholder disclosures.

No. While healthcare is the dominant theme — spanning ophthalmology, veterinary services via its co-investment with KKR in Ruichen Pet Hospital Group, and digital health ventures — the group also deploys into commercial real estate. It owns a portion of Wuhan Poly Cultural Plaza and its own headquarters building in Changsha. The investment mandate is broad, reflecting a founder-family office model rather than a dedicated healthcare fund.

Chen Bang, as Chairman and 79.99% owner, holds ultimate decision authority. Li Li, the Vice Chairman and General Manager, owns the remaining 20.01% and serves as the operational lead. No external investment committee or limited-partner oversight governs their allocations — the group deploys personal capital with the independence of a single-family office.

The group functions as a private investment holding company for Chen Bang and Li Li's personal capital. It does not market funds to external limited partners, nor does it report to institutional backers as a traditional private equity firm would. Publicly known co-investors like KKR are deal-level partners in specific assets rather than fund investors in the group itself.

The group is a willing co-investor when a partner brings operational expertise that complements its healthcare thesis. Its participation alongside KKR in Ruichen Pet Hospital Group demonstrates a preference for contributing local market knowledge and capital to deals led by global private equity firms. Separately, Hillhouse Capital and Temasek are known institutional shareholders in the listed Aier parent, though they invest at the operating-company level, not directly into the investment group.

Chen Bang founded Aier Eye Hospital Group and built it into China's largest private ophthalmology chain with over 600 hospitals. The wealth powering the investment group derives from his controlling equity stake in the Shenzhen-listed company, which at peak valuation exceeded $30 billion in market capitalization. Dividend distributions and occasional share sales have provided the liquidity deployed into venture and real estate assets.

Yes. Chen Bang and Li Li have established the Aier Ophthalmology Charity Foundation and the Xiangjiang Philanthropy Foundation. Public records indicate these are legally separate foundations operating in parallel to the for-profit investment vehicle, though detailed governance documents outlining the separation are not publicly available.